TOWER ONE WIRELESS ANNOUNCES TWENTY-TWO TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 2,600,000

2 years ago

TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF JUNE 2022VANCOUVER, BC, CANADA, July 14, 2022 (GLOBE NEWSWIRE) -- TOWER ONE…

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

2 years ago

BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home…

Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022

2 years ago

CAMBRIDGE, Mass., July 14, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular…

Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome

2 years ago

Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome DUBLIN, Ireland,…

SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022

2 years ago

BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today…

BUSINESS UPDATE

2 years ago

Arecor Therapeutics plc(“Arecor” or the “Group”) BUSINESS UPDATE Pipeline for future revenue generating partnered collaborations is strong with further deals…

Clene Reports Significantly Decreased Mortality in RESCUE-ALS Long-Term Open Label Extension Trial

2 years ago

As of the July 5, 2022, data cutoff, early CNM-Au8® treatment resulted in a significant survival benefit (5 CNM-Au8 deaths…

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2022 Financial Results on July 28, 2022

2 years ago

LEAMINGTON, Ontario, July 14, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY),…

BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners

2 years ago

Enhanced products For Use by Holistic Healthcare Practitioners – $21b US Market For Alternative Medicine Goods and Services LAS VEGAS,…

Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies

2 years ago

Confirmed safety profile at 300 mg/m2 or 1.5 times the therapeutic dose of docetaxel aloneConfirmed low levels of free docetaxel…